Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5730868

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
mmTV-luciferase reporter assay: An AR-response element is contained within the mmTV sequence and drives the expression of luciferase. The effect of antiandrogens (competitive antagonists) on this process is measured by quantifying the amount of luciferase activity after 24 hours in the presence of varying concentrations of antiandrogens. From these values, an IC50 for each antagonist is calculated. Experimentally, HeLa cells were maintained in Dulbecco's modified Eagle's medium H-21 4.5 g/L glucose, containing 10% steroid depleted fetal bovine serum, 50 units/mL penicillin. For transfection, (1×105) cells per well were plated and incubated overnight. A mixture of typically 200 ng of mmTV responsive luciferase reporter plasmid, 10 ng of β-actin-β-galactosidase internal control, 10 ng of AR full length CMV expression vector or empty vector control, and 10-100 ng of β-catenin or empty vector control were mixed with 0.5 μL of transfection reagent from BioRad and incubated for 20 min and then plated in 24 well plate triplicates. Cells were induced with 1 nM DHT and 0.1 nM-30 uM compounds after 3 hrs and then incubated overnight. Cells were collected, and pellets were lysed in 100 μL of 100 mM Tris-HCl (pH 7.5) containing 0.1% Triton X-100. Luciferase and β-galactosidase activities were measured using the Luciferase Assay System (Promega) and Galacto-Light Plus-galactosidase reporter gene assay system (Applied Biosystems), according to the manufacturer's instructions.
24
Total Activities
7
Compounds Tested
3
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

Androgen receptor (CHEMBL1871)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Androgen receptor antagonists
(2018)

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 8 5.31 6.72
kon 8 - -
k_off 8 - -

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL5893645 6 6.72
CHEMBL5740755 3 5.89
CHEMBL1082407 ENZALUTAMIDE 4.0 3 5.07
CHEMBL5744517 3 5.06
CHEMBL5955311 3 4.91
CHEMBL3183409 APALUTAMIDE 4.0 3 4.71
CHEMBL5887736 3 4.14

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL5893645 IC50 = 190.0 nM 6.72
CHEMBL5893645 IC50 = 1000.0 nM 6.00
CHEMBL5740755 IC50 = 1290.0 nM 5.89
CHEMBL1082407 ENZALUTAMIDE IC50 = 8610.0 nM 5.07
CHEMBL5744517 IC50 = 8740.0 nM 5.06
CHEMBL5955311 IC50 = 12400.0 nM 4.91
CHEMBL3183409 APALUTAMIDE IC50 = 19500.0 nM 4.71
CHEMBL5887736 IC50 = 71700.0 nM 4.14
CHEMBL5893645 kon = - -
CHEMBL5893645 k_off = - s-1 -
CHEMBL5893645 kon = - -
CHEMBL5893645 k_off = - s-1 -
CHEMBL5887736 kon = - -
CHEMBL5887736 k_off = - s-1 -
CHEMBL5955311 kon = - -
CHEMBL5955311 k_off = - s-1 -
CHEMBL5744517 kon = - -
CHEMBL5744517 k_off = - s-1 -
CHEMBL1082407 ENZALUTAMIDE kon = - -
CHEMBL1082407 ENZALUTAMIDE k_off = - s-1 -
CHEMBL3183409 APALUTAMIDE kon = - -
CHEMBL3183409 APALUTAMIDE k_off = - s-1 -
CHEMBL5740755 kon = - -
CHEMBL5740755 k_off = - s-1 -